HeraMED Limited (ASX:HMD)
Australia · Delayed Price · Currency is AUD 0.0350
-0.0010 (-2.78%)
Aug 28, 2026, 3:40 PM AEST
HeraMED Cash Flow Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -4.13 | -5.49 | -6.78 | -7.18 | -7.85 |
Depreciation & Amortization | 0.02 | 0.04 | 0.08 | 0.02 | 0.01 |
Other Amortization | 0.12 | 0.29 | 0.59 | 0.5 | 0.37 |
Asset Writedown & Restructuring Costs | 0.63 | - | - | - | 0.13 |
Stock-Based Compensation | 0.12 | 0.36 | 0.04 | 0.68 | 0.55 |
Provision & Write-off of Bad Debts | 0.09 | - | - | - | - |
Other Operating Activities | 0.02 | 0.01 | 0.27 | 2.63 | 2.12 |
Change in Accounts Receivable | 0.08 | 0.29 | -0.13 | -0.02 | -0.01 |
Change in Inventory | - | -0.01 | -0.15 | -0.21 | -0.03 |
Change in Accounts Payable | - | - | - | - | 0.27 |
Change in Unearned Revenue | -0.62 | -0.3 | 0.38 | -0.19 | - |
Operating Cash Flow | -3.66 | -4.81 | -5.71 | -3.77 | -4.44 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -0 | -0.01 | -0.03 |
Sale (Purchase) of Intangibles | - | - | - | -1.01 | -0.09 |
Investing Cash Flow | - | - | -0 | -1.02 | -0.12 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | - | - | - | 2.48 |
Long-Term Debt Issued | - | 0.26 | - | - | - |
Total Debt Issued | - | 0.26 | - | - | 2.48 |
Long-Term Debt Repaid | -0.07 | -0.46 | -0.15 | -0.15 | -0.16 |
Net Debt Issued (Repaid) | -0.07 | -0.2 | -0.15 | -0.15 | 2.32 |
Issuance of Common Stock | 1.98 | 7.08 | 3.19 | 3.89 | 4.56 |
Other Financing Activities | - | - | - | - | -0.16 |
Financing Cash Flow | 1.91 | 6.88 | 3.04 | 3.74 | 6.72 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.01 | 0 | -0.2 | -0.34 | 0.12 |
Net Cash Flow | -1.76 | 2.07 | -2.88 | -1.39 | 2.28 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -3.66 | -4.81 | -5.71 | -3.77 | -4.47 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -847.42% | -1000.44% | -942.64% | -1171.67% | -3751.19% |
Free Cash Flow Per Share | -0.00 | -0.01 | -0.02 | -0.02 | -0.03 |
Levered Free Cash Flow | -2.32 | -2.75 | -3.36 | -4.41 | -3.7 |
Unlevered Free Cash Flow | -2.32 | -2.72 | -3.35 | -3.05 | -2.33 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0 | 0 | 0.01 | 0 | 0 |
Change in Working Capital | -0.54 | -0.02 | 0.1 | -0.42 | 0.23 |